Drusen proteome analysis: An approach to the etiology of age-related macular degeneration
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 3 of the 17 sources its claims cite were checked for support.
Abstract
Drusen are extracellular deposits that accumulate below the retinal pigment epithelium on Bruch's membrane and are risk factors for developing age-related macular degeneration (AMD). The progression of AMD might be slowed or halted if the formation of drusen could be modulated. To work toward a molecular understanding of drusen formation, we have developed a method for isolating microgram quantities of drusen and Bruch's membrane for proteome analysis. Liquid chromatography tandem MS analyses of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins. Immunocytochemical studies have thus far localized ≈16% of these proteins in drusen. Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen. Up to 65% of the proteins identified were found in drusen from both AMD and normal donors. However, oxidative protein modifications were also observed, including apparent crosslinked species of tissue metalloproteinase inhibitor 3 and vitronectin, and carboxyethyl pyrrole protein adducts. Carboxyethyl pyrrole adducts are uniquely generated from the oxidation of docosahexaenoate-containing lipids. By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins. Carboxymethyl lysine, another oxidative modification, was also detected in drusen. These data strongly support the hypothesis that oxidative injury contributes to the pathogenesis of AMD and suggest that oxidative protein modifications may have a critical role in drusen formation.
Overview
CoChat Summary
TL;DR
This study developed a method to isolate microgram quantities of drusen and analyzed their proteome by LC MS/MS, identifying 129 proteins from normal and AMD donor eyes. It reports oxidative protein modifications, especially carboxyethyl pyrrole adducts, that are more abundant in AMD Bruch’s membrane, supporting a role for oxidative injury in AMD pathogenesis.
Key findings
- LC MS/MS of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins: 107 from normal donors and 62 from AMD donors. About 38% (41/107) of normal-donor proteins were also found in AMD donors, and 65% (42/62) of AMD-donor proteins were found in normal donors; 21 of 62 AMD proteins (≈33%) were not observed in normal donor drusen.
- TIMP3, clusterin, vitronectin, and serum albumin were the most common proteins in normal donor drusen, detectable in up to 80% of tissues from the 18 normal donors and 60% of drusen preparations from the five AMD donors. Crystallin was detected more frequently in AMD donor drusen.
- Immunocytochemistry localized ≈16% (21/129) of identified proteins in drusen.
- Oxidative modifications were observed, including apparent crosslinked species of TIMP3 and vitronectin and carboxyethyl pyrrole (CEP) protein adducts. By Western analysis, CEP immunoreactivity was present in 9 of 11 AMD samples versus 2 of 11 age-matched controls (Fischer’s test, P = 0.004 single-sided); carboxymethyl lysine was also detected in drusen.
Methods
- Human donor eyes from 29 normal and 16 AMD donors, ages 56–98 years, were used. Drusen isolation and protein identification used 23 eyes (18 normal, five AMD); Western analyses used 22 eyes (11 normal, 11 AMD). Eyes were enucleated 1.5–7 h after death and frozen.
- Drusen were manually isolated from Bruch’s membrane, proteins were extracted, trypsin-digested, and analyzed by liquid chromatography tandem MS (LC MS/MS) with database searching. Immunocytochemistry and Western analysis were used to confirm drusen localization and detect oxidative modifications.
- For CEP Western analysis, Bruch’s membrane/RPE/choroid from AMD and age- and gender-matched normal donors was subjected to SDS/PAGE (≈20 µg protein per lane) and probed with anti-CEP antibodies.
Limitations
- The paper states that mass spectrometric analyses did not measure protein abundance; the number of proteins identified per drusen preparation varied from 0 to 39 and averaged 19. It also notes that some identified proteins may be soluble contaminants or, as with annexin II, localized to RPE tissue adhering to drusen, and that additional AMD donors are required to establish the significance of the crystallin observation.
- The paper states that whether any drusen protein is uniquely associated with AMD remains to be determined.
- Evident from the text: the AMD proteomic group was small (five donors), many isolated drusen were from far peripheral locations, and immunocytochemical confirmation covered only ≈16% of identified proteins.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 1 Not valid · 8 Not checked · 29 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Among the nine identified immunopositive proteins were albumin and 𝛂 1-antitrypsin, both of which were detected in drusen by LC MS ∕ MS (Table 3) and immunocytochemistry (14).”
What the sources say
- Disputedcites [14] matched to “Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease” (2000) sourceExperimental — accuracy not yet measured
Our copy of Mullins et al. (2000) directly contradicts the attributed point: in the Immunohistochemistry section it states that 'Antibodies directed against human serum albumin and haptoglobin bound strongly to the choroidal stroma, but not to hard or soft drusen,' and Table 1 scores Albumin as negative for drusen (figure legend for panel J repeats that labeling was not generally observed with albumin antibodies). Alpha-1-antitrypsin is likewise not presented as an identified drusen component — the same section reports 'Weak and/or inconsistent drusen labeling of antibodies directed against the protease inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin,' and Table 1 lists it as negative with only rare variable reactions. The proteins the paper does identify in all drusen phenotypes are amyloid P component, apolipoprotein E, immunoglobulin light chains, Factor X and complement C5/C5b-9 (Abstract; Immunohistochemistry), and the study contains no carboxyethylpyrrole/CEP-adduct work and no LC-MS/MS data. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The multiple, higher mass electrophoretic components containing these proteins suggest the presence of covalent crosslinks, protein modifications that can be caused by reactive lipid and carbohydrate oxidation products (22, 23).”
What the sources say
- Partly supportedcites [22] Friguet, B., Stadtman, E. R. & Szweda, L. I. (1994) J. Biol. Chem. 269, 21639-21643. sourceExperimental — accuracy not yet measured
Friguet et al. (1994) directly support the lipid-oxidation half of what the paired citation is offered for: the Cross-linking of Glu-6-PDH by HNE section (Fig. 1) shows progressive appearance of higher-mass multimeric (dimeric, tetrameric) protein on SDS-gel filtration and SDS-gel electrophoresis after exposure to the lipid peroxidation product HNE, i.e. covalent cross-links, and the Discussion/Abstract state this explicitly. Our copy contains no passage attributing cross-linking to carbohydrate oxidation products (searched: carbohydrate/glycation cross-linking — only lipid peroxidation products HNE and malondialdehyde are discussed), so that half of the claim is not supported by this source; the cross-links shown are also formed in vitro on a heterologous bacterial model enzyme at 5 mM HNE, with the Discussion conceding basal in vivo HNE concentrations are ~3 orders of magnitude lower. The citing authors' own observation of higher-mass electrophoretic components containing TIMP-3 and vitronectin is not something this paper reports. (LLM, conf=0.70)
- Partly supportedcites [23] Elgawish, A., Glomb, M., Friedlander, M. & Monnier, V. M. R. (1996) J. Biol. Chem. 271, 12964-12971. sourceExperimental — accuracy not yet measured
Our copy of Elgawish et al. (1996) supports the carbohydrate-oxidation half of the attributed point: the Introduction (p.1) notes that 'metal-catalyzed glucose autoxidation may be more important than glycation for generation of fluorescent protein adducts and cross-links' and that deoxyosones/glyoxal and 'reactive ketoaldehydes might be responsible for collagen cross-linking', and the Discussion proposes an H2O2- and Amadori-product-driven covalent lysine-lysine cross-link. The lipid-oxidation half is not asserted by this paper: in the Discussion it appears only as an alternative model ('H2O2 ... could catalyze collagen cross-linking, e.g. through lipid peroxidation (44)'), which the authors immediately discount for their system ('Lipid peroxidation, however, is unlikely to be involved since many studies have shown that it is not preventable by catalase'). The paper also reports no electrophoretic high-mass protein components (its cross-linking readouts are tendon breaking time, linked fluorescence, CML, pentosidine), so it does not address the TIMP-3/vitronectin observation itself. (LLM, conf=0.72)
hedgedstates an associationSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen.”
- Also stated in: § Results · hedged
“Tissue metalloproteinase inhibitor 3 (TIMP3), clusterin, vitronectin and serum albumin appear to be common drusen proteins, detectable in up to 80% of the tissues from the 18 normal donors”
plainn = 18- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins.”
- Also stated in: § Results · plain
“Western results (Fig. 3) revealed more frequent CEP immunoreactivity among the AMD samples than in the normal controls. Specifically, nine of the 11 AMD samples were immunopositive whereas only two of the 11 age-matched controls were CEP immunoreactive. Statistically these CEP immunoreactivity results are significantly different between AMD and normal donors (Fischer's test, P value = 0.004 single”
plainstates an associationn = 11- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Immunocytochemical studies have thus far localized ≈ 16% of these proteins in drusen.”
- Also stated in: § Discussion · plain
“To verify drusen localization, immunocytochemical studies are ongoing, and to date 21 of the identified proteins (16%) have been confirmed as drusen components in our laboratories and elsewhere.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
20 more claims
Create a free account to see all 39 claims and to verify the 14 references still open.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Biochemical analysis of drusen has identified glycoconjugates and components found in atherosclerotic plaques including vitronectin, apolipoprotein B and E, alpha-crystallin, complement proteins, and lipids (32, 106, 115).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In an AMD patient’s outer retina and plasma, there are more CEP-modified proteins when compared to age-matched controls (Crabb et al., 2002).”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serum albumin is one of the major proteins modified with CEP”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Biochemical analysis of drusen have indeed resulted in identification of complement components and inflammatory modulators [2–8].”
From CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD (2005) · cites this paper as [8]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“immunize mice with CEP-modified mouse serum albumin, generating a strong immunologic response against endogenous CEP adducts in the outer retina”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors.”
Reported 65 · recomputed 67.741935
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion
“About 38% (41 ∕ 107) of the proteins identified from normal donor drusen were also found in drusen from AMD donors”
§ Discussion
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Twenty-one of the 62 proteins detected in drusen from AMD tissue ( ≈ 33%) were not observed in normal donor drusen (Table 3).”
Reported 21 · recomputed 22
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The Role of Oxidative Stress in the Pathogenesis of Age-Related Macular Degeneration
Beatty, S., Koh, H.-H., Phil, M., Henson, D., & Boulton, M. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00140-5 · Cited by 2,051
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Chemistry and metabolism of lipids in the vertebrate retina
Fliesler, A. J., & Anderson, R. E. (1983) · Progress in Lipid Research · doi:10.1016/0163-7827(83)90004-8 · Cited by 1,052
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Ahmed, M. U., Thorpe, S. R., & Baynes, J. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89188-3 · Cited by 864
Identification of the gene responsible for Best macular dystrophy
Petrukhin, K., Koisti, M. J., Bakall, B., Li, W., Xie, G., Marknell, T., Sandgren, O., Forsman, K., Holmgren, G., Andreasson, S., et al. (1998) · Nature Genetics · doi:10.1038/915 · Cited by 689
Positional cloning of the gene associated with X-linked juvenile retinoschisis
Sauer, C. G., Gehrig, A., Warneke-Wittstock, R., Marquardt, A., Ewing, C. C., Gibson, A., Lorenz, B., Jurklies, B., & Weber, B. H. F. (1997) · Nature Genetics · doi:10.1038/ng1097-164 · Cited by 497
Research works printed but not linked: 3
- Midena E., Deglii Angeli, C., Blarzino, M., Valenti, M. & Segato, T. (1997) Invest. Ophthalmol. Visual Sci.38,469-477.9040480
- Kamei M. & Hollyfield, J. E. (1999) Invest. Ophthalmol. Visual Sci.40,2367-2375.10476804
- Handa, J. T., Verzijl, N., Matsunaga, H., Aotaki-Keen, A., Lutty, G. A., te Koppele, J. M., Miyata, T. & Hjelmeland, L. M. (1999) Invest. Ophthalmol. Visual Sci. 40, 775-779.
Cited by
Items 301–400 of 1,000
Tanito, M., Brush, R. S., Elliott, M. H., Wicker, L. D., Henry, K. R., & Anderson, R. E. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800170-jlr200 · Cited by 81
Kumar, Y., & Gupta, S. (2022) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-022-09807-7 · Cited by 91
“Furthermore, images from three datasets were used, including the diseases like Cataract [33, 34] and Glaucoma [35, 36] along with retinal diseases CNV (Choroidal revascularization) [37], DME [38] and DRUSEN [39].”
MethodYaung, J., Jin, M., Barrón, E., Spee, C. K., Wawrousek, E. F., Kannan, R., & Hinton, D. R. (2007) · PubMed Central · Cited by 90
p62 provides dual cytoprotection against oxidative stress in the retinal pigment epithelium.
Wang, L., Cano, M., & Handa, J. T. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.03.016 · Cited by 82
“[30,31], and accumulates in drusen, a hallmark sign of AMD [32], thus, serving as a relevant biomarker for RPE stress.”
Aging of the eye: Lessons from cataracts and age-related macular degeneration
Cvekl, A., & Vijg, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102407 · Cited by 89
“A long mystery of other crystallin proteins in drusen (Crabb et al., 2002) may have an answer originating from response of a small subpopulation of RPE cells to partially dedifferentiate (Stern and Temple, 2015).”
BackgroundGenetics of Immunological and Inflammatory Components in Age-related Macular Degeneration
Tuo, J., Grob, S., Zhang, K., & Chan, C.-C. (2012) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2011.628432 · Cited by 80
Crystallin distribution in Bruch's membrane–choroid complex from AMD and age-matched donor eyes
Nakata, K., Crabb, J. W., & Hollyfield, J. G. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2004.12.011 · Cited by 85
Self-citationC-reactive Protein Level and Risk of Aging Macula Disorder: The Rotterdam Study
Boekhoorn, S. S. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.10.1396 · Cited by 78
Identification of anti-retinal antibodies in patients with age-related macular degeneration
Morohoshi, K., Ohbayashi, M., Patel, N., Chong, V. N., Bird, A. C., & Ono, S. J. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.03.007 · Cited by 85
De, S. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.5.641 · Cited by 80
“Direct proteomic analysis of drusen isolated by microdissection from donor eyes with and without AMD has identified a set of proteins that are more prevalent in drusen from patients with AMD.(6,7) Crystallins are the most abundant proteins found in drusen from donors diagnosed as having AMD.”
BackgroundInfluentialAgonists at the Serotonin Receptor (5-HT1A) Protect the Retina from Severe Photo-Oxidative Stress
Collier, R. J., Patel, Y., Martin, E. A., Dembinska, O., Hellberg, M., Krueger, D. S., Kapin, M. A., & Romano, C. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6304 · Cited by 78
“IOVS 2009;50:ARVO E-Abstract 681), a unique degradation product of docosahexaenoate, found in the retinas of AMD patients.(14) Although the pathogenesis of photo-oxidative-induced retinopathy and AMD are different, this model has been used to evaluate potential therapies to slow the progression of outer retinal degene…”
BackgroundLipids and Age-related Macular Degeneration
Kishan, A. U., Modjtahedi, B. S., Martins, E. N., Modjtahedi, S. P., & Morse, L. S. (2011) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2010.08.008 · Cited by 86
Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy
Hudson, N., Celkova, L., Hopkins, A., Greene, C., Storti, F., Ozaki, E., Fahey, E., Theodoropoulou, S., Kenna, P. F., Humphries, M. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130273 · Cited by 80
“Drusen is composed of extracellular components, including, but not limited to, amyloid-β, vitronectin, cholesterols, and almost every complement component (5).”
BackgroundMinasyan, L., Sreekumar, P. G., Hinton, D. R., & Kannan, R. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1675230 · Cited by 83
Regulated secretion of complement factor H by RPE and its role in RPE migration
Kim, Y. H., He, S., Kase, S., Kitamura, M., Ryan, S. J., & Hinton, D. R. (2009) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1049-y · Cited by 76
Nawrot, M., West, K., Huang, J., Possin, D. E., Bretscher, A., Crabb, J. W., & Saari, J. C. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0989 · Cited by 77
“Identification of EBP50 by liquid chromatography electrospray tandem mass spectrometry LC MS/MS used methods described in detail elsewhere.(31,32) Briefly, stained gel spots or bands were excised, the stain washed away, the proteins digested in gel with trypsin, and the peptides extracted for mass spectrometric analys…”
MethodSelf-citationAlves, C. H., Fernandes, R., Santiago, A. R., & Ambrósio, A. F. (2020) · Cells · doi:10.3390/cells9051217 · Cited by 78
Collier, R. J., Wang, Y., Smith, S. S., Martin, E., Ornberg, R., Rhoades, K., & Romano, C. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6418 · Cited by 78
“Complement components including C3 (and activated fragments), membrane attack complex (MAC), and factor H, are present in drusen as measured immunochemically,(1,2) and some have been verified by mass spectrometry.(3) Genetic variants of complement factor H and other complement components(9,10) have been associated wit…”
BackgroundResultSenabouth, A., Daniszewski, M., Lidgerwood, G. E., Liang, H. H., Hernández, D., Mirzaei, M., Keenan, S. N., Zhang, R., Han, X., Neavin, D. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31707-4 · Cited by 76
Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina
Dasari, B., Prasanthi, J. R. P., Marwarha, G., Singh, B. B., & Ghribi, O. (2011) · BMC Ophthalmology · doi:10.1186/1471-2415-11-22 · Cited by 82
“Recent studies found many drusen constituents including cholesterol, apolipoproteins, and complement components [24,65].”
BackgroundTransformation of the proteasome with age‐related macular degeneration
Ethen, C. M., Hussong, S. A., Reilly, C., Feng, X., Olsen, T. W., & Ferrington, D. A. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.061 · Cited by 77
“Inflammation has been proposed to play an important role in AMD pathology based upon proteomic [22] and immuno-”
BackgroundC-Reactive Protein and the Incidence of Macular Degeneration: Pooled Analysis of 5 Cohorts
Mitta, V. P., Christen, W. G., Glynn, R. J., Semba, R. D., Ridker, P. M., Rimm, E. B., Hankinson, S. E., & Schaumberg, D. A. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.2303 · Cited by 74
“5,6,7 Inflammatory cell debris has also been isolated from the outer surface of the Bruch’s membrane in eyes with AMD.”
BackgroundHallam, D., Collin, J., Bojic, S., Chichagova, V., Buskin, A., Xu, Y., Lafage, L., Otten, E. G., Anyfantis, G., Mellough, C., et al. (2017) · Stem Cells · doi:10.1002/stem.2708 · Cited by 75
Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina
Law, A.-L., Ling, Q., Hajjar, K. A., Futter, C. E., Greenwood, J., Adamson, P., Wavre-Shapton, S. T., Moss, S. E., & Hayes, M. J. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1204 · Cited by 75
Nakamura, M., Yako, T., Kuse, Y., Inoue, Y., Nishinaka, A., Nakamura, S., Shimazawa, M., & Hara, H. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.07.022 · Cited by 81
Targeting MAPK Signaling in Age-Related Macular Degeneration
Kyosseva, S. V. (2016) · Ophthalmology and Eye Diseases · doi:10.4137/oed.s32200 · Cited by 74
Protection from oxidative stress by methionine sulfoxide reductases in RPE cells
Sreekumar, P. G., Kannan, R., Yaung, J., Spee, C. K., Ryan, S. J., & Hinton, D. R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.081 · Cited by 75
A local complement response by RPE causes early-stage macular degeneration
Fernandez-Godino, R., Garland, D. L., & Pierce, E. A. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv287 · Cited by 73
“nents of drusen have been identified, among them, complement components such as C3, complement component H (CFH) and C5 (3,10,11).”
BackgroundDatta, J., Majumder, S., Bai, S., Ghoshal, K., Kutay, H., Smith, D. S., Crabb, J. W., & Jacob, S. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1455 · Cited by 70
“Information protein sequence databases (26, 27).”
Self-citationRetractedStewart, M. (2012) · Clinical Ophthalmology · doi:10.2147/opth.s33372 · Cited by 71
“40,41 Apoptotic cell death is further enhanced by the presence of advanced glycation end products which activate their receptors (RAGE) 42,43 and upregulate nuclear factor-kB.”
Age-related macular degeneration: a target for nanotechnology derived medicines
Birch, D. G., & Liang, F.-Q. (2007) · International Journal of Nanomedicine · doi:10.2147/nano.2007.2.1.65 · Cited by 79
Regulation of signaling events involved in the pathophysiology of neovascular AMD.
Wang, H., & Hartnett, M. E. (2016) · PubMed Central · Cited by 90
Lipid peroxidation of membrane phospholipids in the vertebrate retina
Catalá, Á. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/s131 · Cited by 79
Wang, Y., Kim, H. J., & Sparrow, J. R. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.04.010 · Cited by 76
“Because these AGE-modified proteins are present in deposits (drusen) that accumulate on the basal side of RPE cells in vivo, and drusen are a major risk factor for age-related macular degeneration (AMD) pathogenesis, the photodegradation of bisretinoids may constitute a molecular link to drusen and AMD (Anderson et al…”
Fernandez-Godino, R., Bujakowska, K. M., & Pierce, E. A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx392 · Cited by 71
“The majority of these risk alleles, and the majority of complement components found in the BrM and drusen of AMD patients belong to the alternative pathway (15,16,18,31).”
BackgroundGut Microbiome in Retina Health: The Crucial Role of the Gut-Retina Axis
Scuderi, G., Troiani, E., & Minnella, A. M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.726792 · Cited by 83
“They have been shown to contain many potentially harmful substances, including lipids, lipoproteins, lipofuscin, beta-amyloid, oxidation products, and inflammation-related factors such as complement components, immunoglobulins, molecules of the HLA system, and acute-phase proteins such as fibrinogen, vitronectin, and…”
BackgroundJaffe, G. J., Schmitz-Valckenberg, S., Boyer, D., Heier, J., Wolf-Schnurrbusch, U., Staurenghi, G., Schmidt-Erfurth, U., & Holz, F. G. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.08.024 · Cited by 68
Camelo, S. (2014) · Autoimmune Diseases · doi:10.1155/2014/532487 · Cited by 77
“These results strongly suggest that autoantibodies specifically recognizing CEP-adducted proteins are linked to AMD susceptibility.”
BackgroundInfluentialRole of crystallins in ocular neuroprotection and axonal regeneration
Thanos, S., Böhm, M. R. R., zu Hörste, M. M., Prokosch‐Willing, V., Hennig, M., Bauer, D., & Heiligenhaus, A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.06.004 · Cited by 72
“, 2002), and βB2crystallin mRNA has been reported in various tissues including the retina (Crabb et al., 2002).”
InfluentialPlasma Protein Pentosidine and Carboxymethyllysine, Biomarkers for Age-related Macular Degeneration
Ni, J., Yuan, X., Gu, J., Yue, X., Gu, X., Nagaraj, R. H., & Crabb, J. W. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900127-mcp200 · Cited by 72
“may be catalysts or triggers of AMD pathology (6).”
BackgroundSelf-citationKannan, R., Sreekumar, P. G., & Hinton, D. R. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.05.016 · Cited by 78
“Increase in αB crystallin expression in neurodegenerative diseases such as AMD where it is a component of drusen has been documented [10, 37, 38].”
BackgroundImplications of genetic variation in the complement system in age-related macular degeneration
de Jong, S., Gagliardi, G., Garanto, A., de Breuk, A., Lechanteur, Y. T. E., Katti, S., van den Heuvel, L. P., Volokhina, E. B., & den Hollander, A. I. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100952 · Cited by 71
“CLU, FH, VTN, and the individual components of the C5b-9 complex (C5, C6, C7, C8 and C9) in drusen (Crabb et al., 2002; Wang et al., 2010).”
BackgroundTan, L. X., Germer, C. J., Cunza, N. L., & Lakkaraju, A. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101781 · Cited by 81
Dyslipidemia in age-related macular degeneration
Lin, J. B., Halawa, O. A., Husain, D., Miller, J. W., & Vavvas, D. G. (2022) · Eye · doi:10.1038/s41433-021-01780-y · Cited by 75
“Identification of specific proteins within drusen also support a role for altered lipid homeostasis in AMD pathogenesis [25].”
BackgroundβA3/A1-crystallin in astroglial cells regulates retinal vascular remodeling during development
Sinha, D., Klise, A., Sergeev, Y. V., Hose, S., Bhutto, I. A., Hackler, L., Malpica-Llanos, T., Samtani, S., Grebe, R. R., Goldberg, M. F., et al. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.08.016 · Cited by 73
Cuticular drusen: Stars in the sky
Boon, C. J. F., van de Ven, J. P. H., Hoyng, C. B., den Hollander, A. I., & Klevering, B. J. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.08.003 · Cited by 75
Complement-Associated Deposits in the Human Retina
Seth, A., Cui, J., To, E., Kwee, M., & Matsubara, J. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1072 · Cited by 67
“Drusen from patients with AMD and healthy donors have complement-associated proteins.(8,26,27) To date, the role of complement has been principally studied in diseased eyes, and nothing is known of the changes in complement activation resulting from normal aging in the retina.”
BackgroundMolins, B., Fuentes-Prior, P., Adán, A., Antón, R., Arostegui, J. I., Yagüe, J., & Dick, A. D. (2016) · Scientific Reports · doi:10.1038/srep22889 · Cited by 69
Wyatt, A. R., Yerbury, J. J., Poon, S., Dabbs, R. A., & Wilson, M. R. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)04006-8 · Cited by 75
“extracellular protein deposits in numerous diseases including normal peripheral drusen and macular drusen in age-related macular degeneration patients (Crabb et al., 2002), MAC in renal immunoglobulin deposits (French et al.”
BackgroundAntioxidant Drug Therapy Approaches for Neuroprotection in Chronic Diseases of the Retina
Payne, A., Kaja, S., Naumchuk, Y., Kunjukunju, N., & Koulen, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15021865 · Cited by 73
“Proteins from drusen were also rich in posttranslational oxidative modifications such as carboxyethylpyrrole (CEP) protein adducts and advanced glycosylation end products (AGEs) [29].”
BackgroundGu, X., Sun, M., Gugiu, B., Hazen, S., Crabb, J. W., & Salomon, R. G. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo026721t · Cited by 69
Self-citationCruz‐Guilloty, F., Saeed, A. M., Duffort, S., Cano, M., Ebrahimi, K. B., Ballmick, A., Tan, Y., Wang, H., Laird, J. M., Salomon, R. G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088201 · Cited by 75
“Our CEP mouse model of dry AMD is based on observations from human AMD patients that show elevated levels of CEP in drusen and CEP autoantibodies [9,38].”
BackgroundSelf-citationRabin, D. M., Rabin, R. L., Blenkinsop, T. A., Temple, S., & Stern, J. H. (2012) · Aging · doi:10.18632/aging.100516 · Cited by 75
“Drusen from donors without a diagnosis of AMD had lower to undetectable levels of crystallins and proteins related to amyloid-β (Aβ) production [11-14].”
BackgroundInfluentialSears, A. E., Bernstein, P. S., Cideciyan, A. V., Hoyng, C., Issa, P. C., Palczewski, K., Rosenfeld, P. J., Sadda, S., Schraermeyer, U., Sparrow, J. R., et al. (2017) · Translational Vision Science & Technology · doi:10.1167/tvst.6.5.6 · Cited by 68
“Proteins modified by these dicarbonyls are also detected in drusen.(51) The photo-oxidative processes initiated by RPE bisretinoid could explain”
Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye
Cheng, K., Hsieh, C., Nepali, K., & Liou, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01033 · Cited by 73
Aging of the Retina: Molecular and Metabolic Turbulences and Potential Interventions
Campello, L., Singh, N., Advani, J., Mondal, A. K., Corso‐Díaz, X., & Swaroop, A. (2021) · Annual Review of Vision Science · doi:10.1146/annurev-vision-100419-114940 · Cited by 74
Yaung, J., Kannan, R., Wawrousek, E. F., Spee, C. K., Sreekumar, P. G., & Hinton, D. R. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.11.007 · Cited by 75
“Crabb et al. (2002) using proteomic analysis, reported that crystallins were present in drusen preparations of AMD patients.”
MethodGenetics and molecular pathology of Stargardt-like macular degeneration
Vasireddy, V., Wong, P., & Ayyagari, R. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.01.001 · Cited by 68
“Drusen, the earliest sign of AMD, is an accumulation of extracellular deposits that contains lipofuscin and other proteins (Ben-Shabat et al., 2001; Johnson et al., 2001; Penfold et al., 2001; Ben-Shabat et al., 2002; Barthes et al., 2005; Bressler et al., 2005; Umeda et al., 2005; Crabb et al., 2002; Sakaguchi et al.…”
BackgroundShin, T. M., Isas, J. M., Hsieh, C.-L., Kayed, R., Glabe, C. G., Langen, R., & Chen, J. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-16 · Cited by 67
“In addition, we and others [4,5,26,27,34-36] have observed vitronectin reactivity in all drusen samples analyzed, which are extracellular ocular deposits associated with aged eyes and eyes with age-related macular degeneration.”
BackgroundAge-Related Macular Degeneration: Clinical Findings, Histopathology and Imaging Techniques
Zarbin, M. A., Casaroli-Marano, R. P., & Rosenfeld, P. J. (2014) · Developments in ophthalmology · doi:10.1159/000358536 · Cited by 83
Sorkio, A., Hongisto, H., Kaarniranta, K., Uusitalo, H. M. T., Juuti‐Uusitalo, K., & Skottman, H. (2014) · Tissue Engineering Part A · doi:10.1089/ten.tea.2013.0049 · Cited by 74
“Drusens are rich in ECM proteins such as vitronectin (VN) and many inflammatory markers.(23,33,36,37) Thus, one of the important tasks of transplanted hESC-RPE is to produce sufficient ECM to restore the functions of the damaged BM if no BM mimicking nonbiodegradable biomaterial is used with cells.”
Background670-nm light treatment reduces complement propagation following retinal degeneration
Rutar, M., Natoli, R., Albarracin, R., Valter, K., & Provis, J. M. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-257 · Cited by 71
“Additionally, histological analyses of postmortem AMD eyes indicate that complement components and regulatory proteins are present in drusen deposits (reviewed in [5]), particularly activation products of C3 such as C3d and C3b [69-71].”
BackgroundThe Dark Side of Light: Rhodopsin and the Silent Death of Vision The Proctor Lecture
Remé, C. E. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-1095 · Cited by 77
“IOVS 2004;45:ARVO E-Abstract 1795).(93) Thus, numerous pathogenic stimuli emerge that eventually lead to drusen formation and AMD.”
BackgroundGenetics and genetic testing for age-related macular degeneration
Warwick, A., & Lotery, A. (2018) · Eye · doi:10.1038/eye.2017.245 · Cited by 67
Pluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects
Singh, R. K., Cuzzani, O., Binette, F., Sternberg, H., West, M. D., & Nasonkin, I. O. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9802-4 · Cited by 70
“In dry AMD, disruption of the RPE causes accumulation of drusen (waste products from retinal photoreceptor cells inside and below the RPE cells) [54, 55].”
Lauer, N., Mihlan, M., Hartmann, A., Schlötzer-Schrehardt, U. M., Keilhauer, C. N., Scholl, H. P. N., Issa, P. C., Holz, F. G., Weber, B. H. F., Skerka, C., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002488 · Cited by 75
“It is of interest that histones that are released during necrosis were also identified in drusen (4).”
BackgroundJoseph, K., Kulik, L., Coughlin, B., Kunchithapautham, K., Bandyopadhyay, M., Thiel, S., Thielens, N. M., Holers, V. M., & Rohrer, B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.421891 · Cited by 65
Tang, B., Cai, J., Sun, L. N., Li, Y., Qu, J., Snider, B. J., & Wu, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103364 · Cited by 70
“Atrophy or even death of retinal pigment cells (RPEs) and photoreceptors [37,38] are the major pathological changes in dry age-related macular degeneration (AMD).”
BackgroundQuantitative protein profiling of hippocampus during human aging
Xu, B., Gao, Y., Zhan, S., Xiong, F., Qiu, W., Qian, X., Wang, T., Wang, N., Zhang, D., Yang, Q., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.11.029 · Cited by 69
“Protein extracts were prepared as described elsewhere with modifications (Crabb et al., 2002).”
Epigenetics, microbiota, and intraocular inflammation: New paradigms of immune regulation in the eye
Wen, X., Hu, X., Li, M., Ge, X., Deng, Y., Bible, P. W., & Wei, L. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.01.001 · Cited by 72
Iron promotes oxidative cell death caused by bisretinoids of retina
Ueda, K., Kim, H. J., Zhao, J., Song, Y., Dunaief, J. L., & Sparrow, J. R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722601115 · Cited by 68
“Proteins modified by dicarbonyls are detected in sub-RPE drusen (15, 16) and these dicarbonyls are the same as those released by photodegradation of bisretinoids such as A2E and all-trans-retinal dimer.”
BackgroundA Perspective of AMD Through the Eyes of Immunology
Copland, D. A., Theodoropoulou, S., Liu, J., & Dick, A. D. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.18-23893 · Cited by 66
Kawa, M. P., Machalińska, A., Rogińska, D., & Machaliński, B. (2014) · Journal of Immunology Research · doi:10.1155/2014/483960 · Cited by 73
“, 5, 6, 8 (α, β, and γ), and 9) in the separated and complex form [14, 69].”
BackgroundTanito, M., Haniu, H., Elliott, M. H., Singh, A. K., Matsumoto, H., & Anderson, R. E. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.09.012 · Cited by 66
The complement system and age-related macular degeneration
Sivaprasad, S., & Chong, V. N. (2006) · Eye · doi:10.1038/sj.eye.6702176 · Cited by 74
Keenan, T. D. L., Pickford, C. E., Holley, R. J., Clark, S. J., Lin, W., Dowsey, A. W., Merry, C. L., Day, A. J., & Bishop, P. N. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-14126 · Cited by 65
La Cunza, N., Tan, L. X., Thamban, T., Germer, C. J., Rathnasamy, G., Toops, K. A., & Lakkaraju, A. (2021) · JCI Insight · doi:10.1172/jci.insight.142254 · Cited by 65
Rosenthal, R., Heimann, H., Agostini, H. T., Martin, G., Hansen, L. L., & Strauß, O. (2007) · PubMed Central · Cited by 79
Zhao, Y., Bhattacharjee, S., Jones, B. M., Hill, J. M., Clement, C., Sambamurti, K., Dua, P., & Lukiw, W. J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8886-3 · Cited by 62
“Proteome analysis of drusen shows accumulation of at least 36 proteins with considerable overlap between normal and AMD subjects, suggesting that drusen formation in AMD may be an amplification or intensification of a naturally occurring process [95].”
Antibody therapies and their challenges in the treatment of age-related macular degeneration
Volz, C., & Pauly, D. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.020 · Cited by 74
Oxidative stress: The achilles' heel of neurodegenerative diseases of the retina
Cai, X., & McGinnis, J. F. (2011) · Frontiers in bioscience · doi:10.2741/4033 · Cited by 65
“Direct evidence that oxidative stress is a primary cause of AMD comes from the fact that deposits of lipofuscin (toxic, lipid-rich granules) in the RPE and drusen in the BM of AMD eyes contained oxidized proteins (glycoprotein) and lipids, complement components and amyloid (31-33).”
BackgroundProteomic Approaches to Understanding Age-Related Macular Degeneration
Hollyfield, J. G., Salomon, R. G., & Crabb, J. W. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0067-4_11 · Cited by 66
Self-citationGeographic Atrophy and Choroidal Neovascularization in the Same Eye: A Review
Kaszubski, P. A., Ami, T. B., Saade, C., & Smith, R. T. (2016) · Ophthalmic Research · doi:10.1159/000443209 · Cited by 67
Miceli, M. V., & Jazwinski, S. M. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1327 · Cited by 62
Cholesterol homeostasis in the vertebrate retina: biology and pathobiology
Rao, S. R., & Fliesler, S. J. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr120000979 · Cited by 65
Sreekumar, P. G., Chothe, P. P., Sharma, K. K., Baid, R., Kompella, U. B., Spee, C. K., Kannan, N., Manh, C., Ryan, S. J., Ganapathy, V., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11571 · Cited by 63
Yu, C.-C., Nandrot, E. F., Dun, Y., & Finnemann, S. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.021 · Cited by 61
“Aging of the retina and RPE is associated with increased levels of oxidative damage [24, 25].”
BackgroundA Novel Role of Complement in Retinal Degeneration
Yu, M., Zou, W., Peachey, N. S., McIntyre, T. M., & Liu, J. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10069 · Cited by 61
Protective effects of soft acrylic yellow filter against blue light-induced retinal damage in rats
Tanito, M., Kaidzu, S., & Anderson, R. E. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.08.006 · Cited by 63
The role of epigenetics in age-related macular degeneration
Gemenetzi, M. K., & Lotery, A. J. (2014) · Eye · doi:10.1038/eye.2014.225 · Cited by 67
Raoul, W., Feumi, C., Keller, N., Lavalette, S., Houssier, M., Behar-Cohen, F., Combadière, C., & Sennlaub, F. (2008) · Ophthalmic Research · doi:10.1159/000119860 · Cited by 60
“Lipid-Bloated Subretinal Microglial Cells and Drusen Appearance Ophthalmic Res 2008;40:115–119 119”
BackgroundInfluentialMultiplex analysis of age-related protein and lipid modifications in human Bruch's membrane
Beattie, J. R., Pawlak, A. M., Boulton, M. E., Zhang, J., Monnier, V. M., McGarvey, J. J., & Stitt, A. W. (2010) · The FASEB Journal · doi:10.1096/fj.10-166090 · Cited by 63
Cehofski, L. J., Honoré, B., & Vorum, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050907 · Cited by 67
“[90] studied 18 normal eyes and five eyes from human donors with clinically diagnosed AMD.”
BackgroundEmerging Roles of Redox-Mediated Angiogenesis and Oxidative Stress in Dermatoses
Xian, D., Song, J., Yang, L., Xiong, X., Lai, R., & Zhong, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2304018 · Cited by 68
Bojanowski, C. M., Shen, D., Chew, E. Y., Ning, B., Csaky, K. G., Green, W. R., Chan, C., & Tuo, J. (2006) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20233 · Cited by 62
Rôżanowska, M. (2023) · Antioxidants · doi:10.3390/antiox12122111 · Cited by 66
Whitmore, S. S., Braun, T. A., Skeie, J. M., Haas, C. M., Sohn, E. H., Stone, E. M., Scheetz, T. E., & Mullins, R. F. (2013) · PubMed Central · Cited by 75
Hoppe, G., Chai, Y.-C., Crabb, J. W., & Sears, J. E. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2004.02.001 · Cited by 66
Self-citationIannaccone, A., Giorgianni, F., New, D. D., Hollingsworth, T., Umfress, A. C., Alhatem, A., Neeli, I., Lenchik, N. I., Jennings, B., Calzada, J. I., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145323 · Cited by 69
“Both alphaA- (CRYAA) and alphaB- (CRYAB) crystallins, two members of the small HSP family, accumulate in the BM and subjacent choroidal connective tissue from human AMD tissues, and are abundant in drusen [78, 101, 108].”
BackgroundSupuran, C. T. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1671353 · Cited by 66
Metadata
- Authors
- Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., Salomon, R. G., & Hollyfield, J. G.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-10-21
- Volume
- 99
- Issue
- 23
- Pages
- 14682-14687
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC137479
- OpenAlex
- W2136501493
- Semantic Scholar
- 56777252bd03c9f9e59663891e03c8a458996b5f
- Cited by
- 1,208
- References
- 39
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 35 · 2023: 39 · 2022: 52 · 2021: 56 · 2020: 49 · 2019: 34 · 2018: 65 · 2017: 62 · 2016: 44 · 2015: 56 · 2014: 73 · 2013: 57 · 2012: 69
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Foundation Fighting Blindness
- Cleveland Clinic
- Cleveland Clinic Foundation
- National Institutes of Health (5r01ey002362-23, EY06603)
- National Eye Institute (R56EY014240, EY014239, EY06603, EY 014240, F32EY006603, R01EY006603, R01EY014239, EY 02362, R01EY014240)
- National Institute of General Medical Sciences (R01GM021249, GM 21249)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- drusen, age-related macular degeneration, Bruch's membrane, retinal pigment epithelium, protein oxidation, carboxymethyllysine, vitronectin, clusterin, serum albumin, crystallins, drusen formation, AMD pathogenesis
- MeSH terms
- Aged, Aged, 80 and over, Aging, Choroid, Enzymes, Eye, Eye Proteins, Humans, Macular Degeneration, Middle Aged, Reference Values, Retina, Optic Disk Drusen, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.